Mastoiditis primary prevention: Difference between revisions
Line 22: | Line 22: | ||
** This is correlated with higher levels of [[antibodies]] to acute otitis media cause nontypeable ''[[Haemophilus influenzae]]'', as well as pathogenic outer membrane [[protein]] P6. | ** This is correlated with higher levels of [[antibodies]] to acute otitis media cause nontypeable ''[[Haemophilus influenzae]]'', as well as pathogenic outer membrane [[protein]] P6. | ||
Administering a [[prophylactic]] antibiotic regimen for children at risk for developing recurrent otitis media (such as immunosuppressed children, genetically susceptible): | Administering a [[prophylactic]] antibiotic regimen for children at risk for developing recurrent otitis media (such as immunosuppressed children, genetically susceptible): | ||
* Preferred regimen (1): [[Amoxicillin]] 20 mg/kg po once daily.< | * Preferred regimen (1): [[Amoxicillin]] 20 mg/kg po once daily.<ref name="pmid17054203">{{cite journal| author=Leach AJ, Morris PS| title=Antibiotics for the prevention of acute and chronic suppurative otitis media in children. | journal=Cochrane Database Syst Rev | year= 2006 | volume= | issue= 4 | pages= CD004401 | pmid=17054203 | doi=10.1002/14651858.CD004401.pub2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17054203 }} </ref> | ||
* Preferred regimen (2): [[Sulfisoxazole]] 50 mg/kg po at bedtime.< | * Preferred regimen (2): [[Sulfisoxazole]] 50 mg/kg po at bedtime.<ref name="pmid17054203">{{cite journal| author=Leach AJ, Morris PS| title=Antibiotics for the prevention of acute and chronic suppurative otitis media in children. | journal=Cochrane Database Syst Rev | year= 2006 | volume= | issue= 4 | pages= CD004401 | pmid=17054203 | doi=10.1002/14651858.CD004401.pub2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17054203 }} </ref> | ||
* Alternative Regimen (1): [[TMP-SMX]] 4 mg-20 mg/kg once daily.< | * Alternative Regimen (1): [[TMP-SMX]] 4 mg-20 mg/kg once daily.<ref name="pmid17054203">{{cite journal| author=Leach AJ, Morris PS| title=Antibiotics for the prevention of acute and chronic suppurative otitis media in children. | journal=Cochrane Database Syst Rev | year= 2006 | volume= | issue= 4 | pages= CD004401 | pmid=17054203 | doi=10.1002/14651858.CD004401.pub2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17054203 }} </ref> | ||
==References== | ==References== |
Revision as of 16:43, 5 July 2017
Mastoiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Preventing mastoiditis primarily involves preventing developing otitis media and nasopharyngitis. This is achieved by the pneumococcal and influenza vaccines, frequently washing hands, and avoiding fluid transmission and respiratory droplets from nasopharyngitis patients. Preventing exposure to air pollution as potential middle ear irritants, such as secondhand smoke, contributes to preventing otitis media. For infants, preventative measures include avoiding pacifiers, avoiding daycare enrollment, and breastfeeding until at least 6 months of age. A prophylactic regimen of antibiotics can prevent otitis media in at-risk infants and children.
Primary Prevention
Preventative measures for mastoiditis involve preventing the development of otitis media and nasopharyngitis from infectious pathogens:
- Administering the following vaccinations:[1]
- Washing hands frequently.
- Avoiding fluid transmission with nasopharyngitis patients.
- Avoiding coughing and respiratory droplets from respiratory illness indicative nasopharyngitis.
- Avoiding first or secondhand smoke or other air pollutants with potential for middle ear irritation.[2]
- Avoiding use of pacifiers in infants.
- Avoiding enrollment in daycares.
- Breastfeeding infants until at least 6 months of age.[3]
- This is correlated with higher levels of antibodies to acute otitis media cause nontypeable Haemophilus influenzae, as well as pathogenic outer membrane protein P6.
Administering a prophylactic antibiotic regimen for children at risk for developing recurrent otitis media (such as immunosuppressed children, genetically susceptible):
- Preferred regimen (1): Amoxicillin 20 mg/kg po once daily.[4]
- Preferred regimen (2): Sulfisoxazole 50 mg/kg po at bedtime.[4]
- Alternative Regimen (1): TMP-SMX 4 mg-20 mg/kg once daily.[4]
References
- ↑ Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, Joffe MD, Miller DT, Rosenfeld RM, Sevilla XD, Schwartz RH, Thomas PA, Tunkel DE (2013). "The diagnosis and management of acute otitis media". Pediatrics. 131 (3): e964–99. doi:10.1542/peds.2012-3488. PMID 23439909.
- ↑ "Ear infection - acute: MedlinePlus Medical Encyclopedia".
- ↑ Sabirov A, Casey JR, Murphy TF, Pichichero ME (2009). "Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6". Pediatr. Res. 66 (5): 565–70. doi:10.1203/PDR.0b013e3181b4f8a6. PMC 2783794. PMID 19581824.
- ↑ 4.0 4.1 4.2 Leach AJ, Morris PS (2006). "Antibiotics for the prevention of acute and chronic suppurative otitis media in children". Cochrane Database Syst Rev (4): CD004401. doi:10.1002/14651858.CD004401.pub2. PMID 17054203.